OLA
AMRX icon

Oliver Luxxe Assets’s Amneal Pharmaceuticals AMRX Stock Holding History

Oliver Luxxe Assets’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.46M Sell
84,217
-72,068
-46% -$988K 0.21% 132
2026
Q1 		$1.94M Sell
156,285
-203
-0.1% -$2.73K 0.29% 130
2025
Q4 		$1.97M Buy
+156,488
New +$1.79M 0.3% 116

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Oliver Luxxe Assets's AMRX Position: Q2 2026 in Review

Oliver Luxxe Assets reduced its Amneal Pharmaceuticals (AMRX) stake by 46% in Q2 2026, selling an estimated $988K and leaving 84,217 shares worth $1.46M. The position accounts for 0.21% of the portfolio, ranked #132.

Oliver Luxxe Assets first reported a position in AMRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.97M in Q4 2025. 306 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Oliver Luxxe Assets held 84,217 shares of Amneal Pharmaceuticals worth $1.46M as of Q2 2026.
  • Oliver Luxxe Assets sold 72,068 Amneal Pharmaceuticals shares in Q2 2026, an estimated $988K.
  • Amneal Pharmaceuticals made up 0.21% of Oliver Luxxe Assets's portfolio in Q2 2026, its #132 holding.
  • Oliver Luxxe Assets first reported a position in Amneal Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Oliver Luxxe Assets's Amneal Pharmaceuticals position peaked at $1.97M in Q4 2025.
  • 306 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Oliver Luxxe Assets's 13F filing for Q2 2026, filed 9 Jul 2026.